Levi Garraway. Broad Institute via Youtube
Roche raids Eli Lilly for its next chief medical officer as Sandra Horning plans to step down
We found out Monday morning where Levi Garraway was headed after he left Eli Lilly as head of oncology R&D a few days ago. Roche named Garraway as their new chief medical officer, replacing Sandra Horning, who they say is retiring from the company.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.